Global Muscle Relaxant Drugs Market Insights 2023, Analysis and Forecast to 2030,By Drug type, By Route of Administration , By Distribution Channel
- Published Date : 20-07-2023
- Pages : 100
- Report Id : 40267
- Categories : Healthcare
This report describes the global market size of Muscle Relaxant Drugs Market Size, Share & Trends Report Market from 2018 to 2021 and its CAGR from 2018 to 2021, and also forecasts its market size to the end of 2030 and its expected to grow with a CAGR of 4.38% from 2023 to 2030.
Muscle-relaxing pharmaceuticals, usually referred to as skeletal muscle relaxants or just relaxants, are a family of treatments that work by acting on the central nervous system to ease muscular tension and encourage muscle relaxation. These medications are frequently recommended to treat muscular cramps, stiffness, and related discomfort.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Muscle Relaxant Drugs Market Size, Share & Trends Report Market estimated at US $ million in the year 2022, is projected to reach a revised size of US$ million by 2030, growing at a CAGR of 4.38% during the forecast period 2023-2030. North American market for Muscle Relaxant Drugs Market Size, Share & Trends Report Market is estimated to increase from $million in 2022 to reach $ million by 2030, at a CAGR of 4.38% during the forecast period of 2023 through 2030.
For geography segment, regional supply, demand, major players, price is presented from 2018 to 2030. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Muscle Relaxant Drugs Market Size, Share & Trends Report Market as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Drug Type
Skeletal Muscle Relaxant Drugs
Facial Muscle Relaxant Drugs
Neuromuscular Blocking Agents
Skeletal muscle relaxants are currently used to treat chronic pain and other illnesses; they were formerly approved for the short-term therapy of muscular spasms and back pain. Neuromuscular blocking medications are often used as muscle relaxants because they can facilitate surgical procedures, speed up endotracheal intubation, and simplify mechanical breathing by calming skeletal muscles.Neuromuscular blocking medications are routinely utilised during surgical procedures. The need for drugs that inhibit neuromuscular activity is fueled by the growing number of surgeries, which is driving the growth of this market segment.
By Route of Administration
Oral
Injectable
With a share of 51.21% in 2022, the oral category led the market for muscle relaxants. Oral delivery of medication is the most common route. It is the most preferred approach because of its advantages, such as non-invasiveness, patient compliance, and simplicity of medicine distribution.The administration of this muscle relaxant comes before general anaesthesia. Additionally, the most extensively used brand of an injection used to relax muscles is Botox, which has been well-known for more than 25 years. Injections that relax muscles are most commonly used in anti-aging medication to reduce forehead and eyelid creases and lines.
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Growing awareness and an increase in clinical and hospital visits are the main causes of the dominance. In 2022, retail pharmacies are anticipated to rank as the second-largest distribution channel. Online pharmacies are also expected to become more popular in the near future due to several advantages including convenience, comfort, and flexibility.
By Region
North America
APAC
Europe
South America
Middle East & Africa
By 2022, North America was the global market leader for muscle relaxants. This significant proportion may be due to the increase in government investment, the growth in chronic illness incidence, and the availability of top-notch infrastructure in the North American area.The fastest increase is anticipated to occur in Asia Pacific as a result of the region's increasing need for medicines. Additionally, government investments in R&D are rising, and fast infrastructure development is another element promoting regional prosperity.
By Company
Amneal Pharmaceuticals LLC
Ipsen Biopharmaceuticals, Inc.
Merz Pharmaceuticals, LLC.
Par Pharmaceutical
Endo Pharmaceuticals
Vertical Pharmaceuticals
Mallinckrodt
SteriMax
Eisai Co., Ltd.
Metacel Pharmaceuticals, LLC.
Teva Pharmaceuticals USA, Inc.
Please ask for sample pages for full companies list
Base Year: 2022
Historical Data: from 2018 to 2021
Forecast Data: from 2023 to 2030
Any special requirements about this report, please let us know and we can provide custom report.
TABLE OF CONTENTS
1 REPORT OVERVIEW
1.1 MARKET INTRODUCTION
1.2 KEY MARKET SEGMENTS
1.3 PLAYERS COVERED
1.4 MARKET ANALYSIS BY TYPE
1.4.1 Global Muscle Relaxant Drugs Market Size Growth Rate by Drug Type(2018-2030)
1.5 MARKET BY DISTRIBUTION CHANNEL
1.5.1 Global Muscle Relaxant Drugs Market Share by DISTRIBUTION CHANNEL (2018-2030)
1.6 STUDY OBJECTIVES
1.7 YEARS CONSIDERED
2 GLOBAL GROWTH TRENDS
2.1 GLOBAL Muscle Relaxant Drugs Market SIZE
2.2 REGULATORY FRAMEWORK
2.3 IMPACT OF COVID-19
2.4 RUSSIA-UKRAINE CRISIS IMPLICATIONS
2.5 INDUSTRY TRENDS
2.5.1 Market Top Trends
2.5.2 Market Drivers
2.5.3 Market Restraints
2.5.4 Market Opportunities
2.5.5 Porter�s Five Forces Analysis
2.5.6 PESTLE Analysis
2.5.7 SWOT Analysis
2.5.8 Opportunity Orbit
2.5.9 Drug TypeRoadmap
2.5.10 Go to Market Strategy
3 ANALYSIS OF DATA BY Drug Type AND DISTRIBUTION CHANNEL
3.1 GLOBAL Muscle Relaxant Drugs Market SIZE BY Drug Type(2018-2030)
3.2 GLOBAL Muscle Relaxant Drugs Market SIZE BY DISTRIBUTION CHANNEL (2018-2030)
4 NORTH AMERICA
4.1 NORTH AMERICA Muscle Relaxant Drugs Market (2018-2030)
4.2 NORTH AMERICA Muscle Relaxant Drugs Market SIZE BY TYPE
4.3 NORTH AMERICA Muscle Relaxant Drugs Market SIZE BY DISTRIBUTION CHANNEL
4.4 NORTH AMERICA Muscle Relaxant Drugs Market SIZE BY COUNTRY
5 EUROPE
5.1 EUROPE Muscle Relaxant Drugs Market (2018-2030)
5.2 EUROPE Muscle Relaxant Drugs Market SIZE BY TYPE
5.3 EUROPE Muscle Relaxant Drugs Market SIZE BY DISTRIBUTION CHANNEL
5.4 EUROPE Muscle Relaxant Drugs Market SIZE BY COUNTRY
6 ASIA PACIFIC
6.1 ASIA PACIFIC Muscle Relaxant Drugs Market (2018-2030)
6.2 ASIA PACIFIC Muscle Relaxant Drugs Market SIZE BY TYPE
6.3 ASIA PACIFIC Muscle Relaxant Drugs Market SIZE BY DISTRIBUTION CHANNEL
6.4 ASIA PACIFIC Muscle Relaxant Drugs Market SIZE BY COUNTRY
7 SOUTH AMERICA
7.1 SOUTH AMERICA Muscle Relaxant Drugs Market (2018-2030)
7.2 SOUTH AMERICA Muscle Relaxant Drugs Market SIZE BY TYPE
7.3 SOUTH AMERICA Muscle Relaxant Drugs Market SIZE BY DISTRIBUTION CHANNEL
7.4 SOUTH AMERICA Muscle Relaxant Drugs Market SIZE BY COUNTRY
8 MIDDLE-EAST & AFRICA
8.1 MIDDLE-EAST & AFRICA Muscle Relaxant Drugs Market (2018-2030)
8.2 MIDDLE-EAST & AFRICA Muscle Relaxant Drugs Market SIZE BY TYPE
8.3 MIDDLE-EAST & AFRICA Muscle Relaxant Drugs Market SIZE BY DISTRIBUTION CHANNEL
8.4 MIDDLE-EAST AFRICA Muscle Relaxant Drugs Market SIZE BY COUNTRY
9 KEY PLAYERS PROFILES
9.1Amneal Pharmaceuticals LLC
9.1.1 Company Details
9.1.2 Business Overview
9.1.3 TYPEs & Services
9.1.4 Financial Overview (2018-2030)
9.1.5 Recent Development
9.2 Ipsen Biopharmaceuticals, Inc.
9.2.1 Company Details
9.2.2 Business Overview
9.2.3 TYPEs & Services
9.2.4 Financial Overview (2018-2030)
9.2.5 Recent Development
9.3 Merz Pharmaceuticals, LLC.
9.3.1 Company Details
9.3.2 Business Overview
9.3.3 TYPEs & Services
9.3.4 Financial Overview (2018-2030)
9.3.5 Recent Development
9.4Par Pharmaceutical
9.5 Endo Pharmaceuticals
9.6 Vertical Pharmaceuticals
9.7 COMPANY 7*
9.8 COMPANY 8*
9.9 COMPANY 9*
9.10 COMPANY 10*
10 MARKET SHARE BY KEY PLAYERS
10.1 Muscle Relaxant Drugs Market SIZE BY PLAYERS
10.1.1 Global Muscle Relaxant DrugsRevenue by Players (2021)
10.1.2 Global Muscle Relaxant DrugsRevenue Market Share by Players (2021)
10.2 MOST ADOPTED STRATEGIES
10.3 MOST ACTIVE COMPANIES
10.4 MARKET COMPETITION ANALYSIS
11 APPENDIX
11.1 RESEARCH METHODOLOGY
11.2 PRIMARY RESEARCH
11.3 SECONDARY RESEARCH
11.4 DISCLAIMER
LIST OF TABLES
Table 1. Muscle Relaxant DrugsKey Players Covered in 2021
Table 2. Global Muscle Relaxant Drugs Market Size Growth Rate by Drug Type(2018-2030) (Million US$)
Table 3. Global Muscle Relaxant Drugs Market Size Growth by DISTRIBUTION CHANNEL (2018-2030) (Million US$)
Table 4. Key Trends
Table 5. Key Drivers: Impact Analysis (2018-2030)
Table 6. Key Restraints
Table 7. Global Muscle Relaxant Drugs Market Size by Drug Type(2018-2030) (Million US$)
Table 8. Global Muscle Relaxant Drugs Market Size Share by Drug Type(2018-2030)
Table 9. Global Muscle Relaxant Drugs Market Size Share by DISTRIBUTION CHANNEL (2018-2030)
Table 10. North America Muscle Relaxant Drugs Market Size Share by Drug Type(2018-2030)
Table 11. North America Muscle Relaxant Drugs Market Size by DISTRIBUTION CHANNEL (2018-2030) (Million US$)
Table 12. North America Muscle Relaxant Drugs Market Size Share by DISTRIBUTION CHANNEL (2018-2030)
Table 13. North America Muscle Relaxant Drugs Market Size by country (2018-2030) (Million US$)
Table 14. North America Muscle Relaxant Drugs Market Share by country (2018-2030)
Table 15. By Country
Table 16. Europe Muscle Relaxant Drugs Market Size by Drug Type(2018-2030) (Million US$)
Table 17. Europe Muscle Relaxant Drugs Market Share by Drug Type(2018-2030)
Table 18. Europe Muscle Relaxant Drugs Market Size by DISTRIBUTION CHANNEL (2018-2030) (Million US$)
Table 19. Europe Muscle Relaxant Drugs Market Share by DISTRIBUTION CHANNEL (2018-2030)
Table 20. Europe Muscle Relaxant Drugs Market Size by country (2018-2030) (Million US$)
Table 21. Europe Muscle Relaxant Drugs Market share by country (2018-2030)
Table 22. Asia Pacific Muscle Relaxant Drugs Market Size by Drug Type(2018-2030) (Million US$)
Table 23. Asia Pacific Muscle Relaxant Drugs Market Share by Drug Type(2018-2030)
Table 24. Asia Pacific Muscle Relaxant Drugs Market Size by DISTRIBUTION CHANNEL (2018-2030) (Million US$)
Table 25. Asia Pacific Muscle Relaxant Drugs Market Share by DISTRIBUTION CHANNEL (2018-2030)
Table 26. APAC Muscle Relaxant Drugs Market Size by country (2018-2030) (Million US$)
Table 27. APAC Muscle Relaxant Drugs Market share by country (2018-2030)
Table 28. South America Muscle Relaxant Drugs Market Size by Drug Type(2018-2030) (Million US$)
Table 29. South America Muscle Relaxant Drugs Market Share by Drug Type(2018-2030)
Table 30. South America Muscle Relaxant Drugs Market Size by DISTRIBUTION CHANNEL (2018-2030) (Million US$)
Table 31. South America Muscle Relaxant Drugs Market Share by DISTRIBUTION CHANNEL (2018-2030)
Table 32. South America Muscle Relaxant Drugs Market Size by country (2018-2030) (Million US$)
Table 33. South America Muscle Relaxant Drugs Market share by country (2018-2030)
Table 34. The Middle-East & Africa Muscle Relaxant Drugs Market Size by Drug Type(2018-2030) (Million US$)
Table 35. The Middle-East & Africa Muscle Relaxant Drugs Market Share by Drug Type(2018-2030)
Table 36. The Middle-East & Africa Muscle Relaxant Drugs Market Size by DISTRIBUTION CHANNEL (2018-2030) (Million US$)
Table 37. The Middle-East & Africa Muscle Relaxant Drugs Market Share by DISTRIBUTION CHANNEL (2018-2030)
Table 38. The MEA Muscle Relaxant Drugs Market Size by country (2018-2030) (Million US$)
Table 39. The MEA Muscle Relaxant Drugs Market share by country (2018-2030)
Table 40.Amneal Pharmaceuticals LLC Details
Table 41. Business Overview
Table 42. TYPEs & services
Table 43. Financial Overview (2018-2030) (Million US$)
Table 44. Recent Development
Table 45. Ipsen Biopharmaceuticals, Inc. Details
Table 46. Business Overview
Table 47. TYPEs & services
Table 48. Financial Overview (2018-2030) (Million US$)
Table 49. Recent Development
Table 50. Merz Pharmaceuticals, LLC. Company Details
Table 51. Business Overview
Table 52. TYPEs & services
Table 53. Financial Overview (2018-2030) (Million US$)
Table 54. Recent Development
Table 55. Global Muscle Relaxant DrugsRevenue by Players (2021) (Million US$)
Table 56. Global Muscle Relaxant Drugs Market Share by Players (2021)
?
LIST OF FIGURES
Figure 1. Global Muscle Relaxant Drugs Market Share by Drug Typein 2021 & 2028
Figure 2. Global Muscle Relaxant Drugs Market Share by DISTRIBUTION CHANNEL in 2021 & 2028
Figure 3. Muscle Relaxant DrugsReport Years Considered
Figure 4. Global Muscle Relaxant Drugs Market Size and Growth Rate 2018-2030 (Million US$)
Figure 5. Porter's Five Forces Analysis
Figure 6. Global Muscle Relaxant Drugs Market Size by Drug Type Growth Rate 2018-2030 (Million US$)
Figure 7. Global Muscle Relaxant Drugs Market Size by DISTRIBUTION CHANNEL Growth Rate 2018-2030 (Million US$)
Figure 8. North America Muscle Relaxant Drugs Market Size 2018-2030 (Million US$)
Figure 9. Europe Muscle Relaxant Drugs Market Size 2018-2030 (Million US$)
Figure 10. Asia Pacific Muscle Relaxant Drugs Market Size 2018-2030 (Million US$)
Figure 11. South America Muscle Relaxant Drugs Market Size 2018-2030 (Million US$)
Figure 12. The Middle-East & Africa Muscle Relaxant Drugs Market Size 2018-2030 (Million US$)
Figure 1.Amneal Pharmaceuticals LLC Revenue in (2019-2021)
Figure 2. Revenue Growth Rate (2018-2030)
Figure 3. Revenue Growth Rate in (2018-2030)
Figure 4. Global Muscle Relaxant Drugs Market Share by Players in 2021
Direct Purchase
Your perfect start with Stats And ResearchWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Stats And Research Copyright © 2024 .